Cite
APA Citation
Guo, C., Yu, Y., Chakrabarti, J., Piha‐Paul, S. A., Moroose, R., Plotka, A., Shi, H., Durairaj, C., Wang, D. D., & Wainberg, Z. A. (2022). evaluation of pharmacokinetics and safety of talazoparib in patients with advanced cancer and varying degrees of hepatic impairment. British journal of clinical pharmacology, 88(7), 3392–3403. http://access.bl.uk/ark:/81055/vdc_100156707674.0x00003d